Kurto Moerck is a Partner with Validant, based in the EMEA region.
Kurt E. Moerck, Ph.D. is a GMP Quality and Compliance professional with over 39 years´ experience within the Pharmaceutical, Medical Device and Healthcare Industry, including over 30 years’ Global Experience at 3 of the largest Worldwide Pharmaceutical Companies: SmithKline Beecham, Sanofi-Aventis and Sandoz/Novartis, as well as Alcon Labs.
Kurt’s leadership responsibilities have included establishing and directing effective Audit and Compliance programs at SmithKline Beecham, Sanofi-Aventis and Sandoz/Novartis and these responsibilities involved all sites in the USA, Europe, LATAM & Asia. Kurt also has extensive experience in the Quality and Compliance aspects of R&D operations, including Clinical Trials materials, having been responsible for R&D Quality at Rhone Poulenc Rorer/Aventis. Responsibilities have also included Global Senior Advisor and Consultant for Quality & Compliance for Sandoz/Novartis, Sanofi-Aventis and SmithKline Beecham. Having been involved in almost 100 inspections over the last 7 years Kurt gained a positive reputation with the Food and Drug Agency.
Kurt has vast experience in most dosage forms, including all forms of Drug Product, Drug Substance, Biologicals/Biotech, Vaccines, Medical Devices, Combination Products, OTC Products Fractionated Plasma Products and Radiopharmaceuticals from both the quality and manufacturing perspective.
As Associate V.P. Global Audit and Compliance, Sanofi-Aventis and Executive Director QA, directed Quality aspects of two Consent Decrees, allowing for the lifting of shipping and production restrictions. Kurt has also been actively involved with resolving multiple Warning Letter issues
Kurt earned a B.S. from Florida Southern College and his M.S. and Ph.D. Degrees from North Carolina State University. In addition, Kurt is fluent in English and German, both spoken and written.